Research study for healthy women ages 40 -65 who are experiencing hot flashes


17199

A Phase 3, Double-Blind-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Estradiol in Combination with Progesterone in Postmenopausal Women with an Intact Uterus: Estradiol to reduce the Frequency and Severity of Vasomotor Symptoms and Progesterone to Manage the Incidence of Endometrial Hyperplasia

Obstetrics & Gynecology

Pinkerton JoAnn, V

The purpose of this study is to test the safety and effectiveness of an investigational hormone medication for treatment of hot flashes. The study involves 8 visits over 12-13 months. * You will receive study medication, physical exam, pelvic exam with Pap smear, endometrial biopsy and mammogram at no cost to you. * Compensation for the study is up to $800 on study completion. Contact Information: For more information please contact: • Midlife Health Clinical Research Office • 434.243.4722 • IRB-HSR # 17199 Principal Investigator: JoAnn Pinkerton, MD UVa Health System, Department of OB/GYN, Midlife Health Clinic


Adult

Menopause
Hot Flash

Women's Health

Ill

Compensation for the study is up to $800 on study completion.

None None